Roy R Hantgan Selected Research

5-hydroxy-6,8,11,14-eicosatetraenoic acid

10/2005

5-Oxo-ETE analogs and the proliferation of cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roy R Hantgan Research Topics

Disease

2	Atherosclerosis 02/2015 - 09/2013
2	Thrombosis (Thrombus) 01/2013 - 06/2005
2	Neoplasms (Cancer) 10/2012 - 10/2005
1	Septic Shock (Toxic Shock Syndrome) 01/2018
1	Lung Injury 01/2018
1	Sepsis (Septicemia) 01/2018
1	Shock 01/2018
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Wounds and Injuries (Trauma) 04/2013
1	Hypothermia 03/2013
1	Hemorrhage 03/2013
1	Acidosis 03/2013
1	Rupture 01/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2013
1	Meningioma (Meningiomas) 10/2012
1	Nerve Sheath Neoplasms (Nerve Sheath Neoplasm) 10/2012
1	Glioblastoma (Glioblastoma Multiforme) 10/2012
1	Primary Hyperoxaluria (Oxaluria, Primary) 01/2011
1	Vascular System Injuries 11/2010
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 06/2008
1	Sickle Cell Anemia (Hemoglobin S Disease) 12/2004

Drug/Important Bio-Agent (IBA)

2	Hemoglobins (Hemoglobin)IBA 01/2018 - 12/2004
2	oxidized low density lipoproteinIBA 02/2015 - 09/2013
2	cholesteryl oleateIBA 02/2015 - 09/2013
2	Proteoglycans (Proteoglycan)IBA 02/2015 - 09/2013
2	EnzymesIBA 09/2013 - 01/2011
2	Pharmaceutical PreparationsIBA 04/2013 - 01/2013
2	Biocompatible Materials (Biomaterials)IBA 04/2013 - 03/2013
2	Hemostatics (Antihemorrhagics)IBA 03/2013 - 11/2010
2	IntegrinsIBA 01/2013 - 11/2010
2	LigandsIBA 10/2012 - 11/2010
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2018
1	HaptoglobinsIBA 01/2018
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2018
1	IronIBA 01/2018
1	Oleic Acid (Oleate)IBA 02/2015
1	BiglycanIBA 09/2013
1	AcyltransferasesIBA 09/2013
1	Keratins (Keratin)IBA 03/2013
1	lysyl- tyrosyl- glycyl- cysteinyl- homoarginyl- glycyl- aspartyl- tryptophyl- prolyl- cysteine cyclic (4-10)-disulfideIBA 01/2013
1	estropipate (Ogen)FDA LinkGeneric 01/2013
1	FibrinIBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 10/2012
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 10/2012
1	Interleukin-13IBA 10/2012
1	4-hydroxy-2-oxoglutarate aldolaseIBA 01/2011
1	OxalatesIBA 01/2011
1	Hydroxyproline (4 Hydroxyproline)IBA 01/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2008
1	haptoglobin-hemoglobin complexIBA 06/2008
1	GTP-Binding Proteins (G-Protein)IBA 10/2005
1	5-oxo-eicosatetraenoic acidIBA 10/2005
1	Messenger RNA (mRNA)IBA 10/2005
1	5-oxo-6,8,11,14-eicosatetraenoic acidIBA 10/2005
1	5-hydroxy-6,8,11,14-eicosatetraenoic acidIBA 10/2005
1	Pertussis ToxinIBA 10/2005
1	Sickle HemoglobinIBA 12/2004

Therapy/Procedure

1	Therapeutics 01/2018
1	Hemodilution 03/2013
1	Thrombolytic Therapy 06/2005